PerkinElmer Inc. (NYSE:PKI) agreed to buy Signature Genomic Laboratories LLC for an undisclosed sum.
The Waltham, Mass.-based diagnostics and lab equipment maker said it will acquire Spokane, Wash.-based Signature, which performs several types of screening for pre-natal and post-natal genetic diseases, as well as cytogenetic testing of chromosome abnormalities in individuals with unexplained physical and developmental disabilities.